The present investigation dealt with molecular modelling (docking) of the potent compounds showing their anticancer activities targeting cervical carcinoma HeLa cell line and breast cancer cell line MCF-7 for BCL-2 XL and EGFR. The gene discussed is EGFR; the disease is breast cancer.